PlumX Metrics
Embed PlumX Metrics

High incidence of Epstein–Barr virus, cytomegalovirus, and human-herpes virus-6 reactivations in critically ill patients with COVID-19

Infectious Diseases Now, ISSN: 2666-9919, Vol: 51, Issue: 3, Page: 296-299
2021
  • 130
    Citations
  • 0
    Usage
  • 125
    Captures
  • 1
    Mentions
  • 212
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

  • Citations
    130
  • Captures
    125
  • Mentions
    1
    • News Mentions
      1
      • News
        1
  • Social Media
    212
    • Shares, Likes & Comments
      212
      • Facebook
        212

Most Recent News

Risk factors for mortality in kidney transplant recipients with COVID‐19: a single centre experience and case–control study

Devprakash Choudhary   ORCID: orcid.org/0000-0002-5804-51431, Deepesh Kenwar   ORCID: orcid.org/0000-0002-8357-15081, Ajay Sharma   ORCID: orcid.org/0000-0003-4050-65862, Ashish Bhalla   ORCID: orcid.org/0000-0001-5210-10123, Sarbpreet Singh   ORCID: orcid.org/0000-0002-1072-73051,

Article Description

Systemic reactivation of herpesviruses may occur in intensive care unit (ICU) patients and is associated with morbidity and mortality. Data on severe Coronavirus disease-19 (COVID-19) and concomitant reactivation of herpesviruses are lacking. We selected patients admitted to ICU for confirmed COVID-19 who underwent systematic testing for Epstein–Barr virus (EBV), cytomegalovirus (CMV) and human-herpes virus-6 (HHV-6) DNAemia while in the ICU. We retrospectively analysed frequency, timing, duration and co-occurrence of viral DNAemia. Thirty-four patients were included. Viremia with EBV, CMV, and HHV-6 was detected in 28 (82%), 5 (15%), and 7 (22%) patients, respectively. EBV reactivation occurred early after ICU admission and was associated with longer ICU length-of-stay. While in the ICU, critically ill patients with COVID-19 are prone to develop reactivations due to various types of herpesviruses.

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know